AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Atherosclerosis protection afforded to some. (Estradiol Therapy).

OB GYN News

| January 15, 2002 | Bates, Betsy | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ASHLAND, ORE. -- Obese postmenopausal women on lipid-lowering therapy appear to derive no additional protection against atherosclerosis when they take unopposed estradiol, but obese and nonobese women with normal cholesterol levels do seem to benefit.

That was the conclusion of a subgroup analysis of data derived from the Estrogen in the Prevention of Atherosclerosis Trial (EPAT), a randomized, double-blind, placebo-controlled trial that examined progression of subclinical atherosclerosis in healthy postmenopausal women. Results were presented in poster form at the annual meeting of the Pacific Coast Obstetrical and Gynecological Society.

In the study, 199 women were randomized to receive either unopposed estradiol or placebo. Progression of atherosclerosis was evaluated using sequential tests to detect changes in intima media thickness over 2 years.

A cutoff of 30 kg/[m.sup.2] was ...

Related articles from newspapers, magazines, journals, and more
Topical estrogen for postmenopausal women.(Consultation)
Magazine article from: Clinical Advisor Stpyker, Morgan September 1, 2009 700+ words
Is there a recommended duration of topical estradiol therapy for postmenopausal women with symptoms of vulvovaginal atrophy? Would progesterone help counteract endometrial hyperplasia? If so, is there a recommended...
Estradiol therapy prevents uncoordinated bladder muscle function in rats.
Newspaper article from: Biotech Week June 23, 2004 700+ words
2004 JUN 23 - (NewsRx.com & NewsRx.net) -- In ovariectomized rats, low estrogen levels cause uncoordinated bladder muscle function; this can be rectified by estradiol supplementation, study results show. "Whether estrogens have a beneficial effect in the urinary bladder to prevent or to delay
Health issues in postmenopausal women who drink.
Magazine article from: Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
For more facts and information, see all results

Source: HighBeam Research, Atherosclerosis protection afforded to some. (Estradiol Therapy).

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA